Taysha Gene Therapies (TSHA) Non Operating Interest Expenses (2020 - 2026)
Taysha Gene Therapies (TSHA) recorded Non Operating Interest Expenses of $6,000 in Q2 2026, down 64.7% from $17,000 a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
On a TTM basis, Taysha Gene Therapies' Non Operating Interest Expenses came in at $42,000 as of Jun 30, 2026, down 48.8% year-over-year; for FY2025, it was $63,000, down 38.2% from FY2024.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- Across earlier years, Non Operating Interest Expenses came in at $102,000 in FY2024 (-98.0%), $5 million in FY2023 (+31.6%), $3.8 million in FY2022 (+166.0%) and $1.43 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non Operating Interest Expenses since Q3 2020.
- On a year-over-year basis, Non Operating Interest Expenses has declined for 11 consecutive quarters, with an average decline of 58.4% over the last eight quarters.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 283.0% in Q2 2022, against a decline of 98.4% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $9,000 (Q1 2026), $12,000 (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 713,000.00 |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | 672,000.00 |
| Dec 31, 2021 | 691,000.00 |
| Sep 30, 2021 | 543,000.00 |
API Access
Taysha Gene Therapies Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();